Dietary α-linolenic acid and total ω-3 fatty acids are inversely associated with abdominal aortic calcification in older women, but not in older men

Journal of Nutrition

Volumn 145, Issue 8, 2015, Pages 1778-1786

  Shang, Xianwen ^a,b   Sanders, Kerrie M ^a,c   Scott, David ^a,b,d   Khan, Belal ^a,b,e   Hodge, Allison ^f   Khan, Nayab ^g   English, Dallas R ^f   Giles, Graham G ^f   Ebeling, Peter R ^b,d  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b Australian Institute for Musculoskeletal Sciences   (Australia)

^c AUSTRALIAN CATHOLIC UNIVERSITY   (Australia)

^d SOUTHERN HEALTH   (Australia)

^e Max Super Speciality Hospital   (India)

^f CANCER EPIDEMIOLOGY CENTRE   (Australia)

^g Diwan Chand Satyapal Aggarwaal Diagnostic Imaging Research Centre   (India)

Author keywords

Abdominal aortic calcification; Decosahexaenoic acid; Eicosapentaenoic acid; linolenic acid; 3 fatty acids

Indexed keywords

LINOLENIC ACID; OMEGA 3 FATTY ACID;

ABDOMINAL AORTA CALCIFICATION; ADULT; AORTA DISEASE; ARTICLE; CALCIFICATION; CALORIC INTAKE; COHORT ANALYSIS; DIETARY INTAKE; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NUTRITIONAL ASSESSMENT; SENSITIVITY ANALYSIS; SPINE RADIOGRAPHY; THORACOLUMBAR SPINE; ABDOMINAL AORTA; AGED; AGING; CALCINOSIS; DIET; DOSE RESPONSE; DRUG EFFECTS; NUTRITION; PATHOLOGY; RISK FACTOR; SEX DIFFERENCE;

AGED; AGING; ALPHA-LINOLENIC ACID; AORTA, ABDOMINAL; CALCINOSIS; DIET; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; RISK FACTORS; SEX FACTORS;

EID: 84938927927     PISSN: 00223166     EISSN: 15416100     Source Type: Journal    
DOI: 10.3945/jn.115.211789     Document Type: Article

References (49)

1. Russo GL. Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 2009;77:937-46.
2. Mann NJ, Johnson LG, Warrick GE, Sinclair AJ. The arachidonic acid content of the Australian diet is lower than previously estimated. J Nutr 1995;125:2528-35.
3. National Heart Foundation of Australia. Review of evidence: fish, fish oils, n-3 polyunsaturated fatty acids and cardiovascular health. Brisbane (Australia): NHFA; 2008.
4. National Health and Medical Research Council. Nutrient Reference Values for Australia and New Zealand including Recommended Dietary Intakes. Canberra (Australia): NHMRC; 2006.
5. de Goede J, Verschuren WM, Boer JM, Kromhout D, Geleijnse JM. Gender-specific associations of marine n-3 fatty acids and fish consumption with 10-year incidence of stroke. PLoS ONE 2012;7: e33866.
6. Campos H, Baylin A, Willett WC. Alpha-linolenic acid and risk of nonfatal acute myocardial infarction. Circulation 2008;118:339-45.
7. Hu FB, Stampfer MJ, Manson JE, Rimm EB, Wolk A, Colditz GA, Hennekens CH, Willett WC. Dietary intake of alpha-linolenic acid and risk of fatal ischemic heart disease among women. Am J Clin Nutr 1999;69:890-7.
8. de Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL, Monjaud I, Guidollet J, Touboul P, Delaye J. Mediterranean alpha-linolenic acidrich diet in secondary prevention of coronary heart disease. Lancet 1994; 343:1454-9.
9. Pan A, Chen M, Chowdhury R, Wu JH, Sun Q, Campos H, Mozaffarian D, Hu FB. Alpha-linolenic acid and risk of cardiovascular disease: a systematic review and meta-analysis. Am J Clin Nutr 2012; 96:1262-73.
10. Kromhout D, Yasuda S, Geleijnse JM, Shimokawa H. Fish oil and omega-3 fatty acids in cardiovascular disease: do they really work? Eur Heart J 2012;33:436-43.
11. Mori TA. Dietary n-3 PUFA and CVD: a review of the evidence. Proc Nutr Soc 2014;73:57-64.
12. Allison MA, Criqui MH, Wright CM. Patterns and risk factors for systemic calcified atherosclerosis. Arterioscler Thromb Vasc Biol 2004; 24:331-6.
13. Wayhs R, Zelinger A, Raggi P. High coronary artery calcium scores pose an extremely elevated risk for hard events. J Am Coll Cardiol 2002; 39:225-30.
14. Zhu D, Mackenzie NC, Farquharson C, Macrae VE. Mechanisms and clinical consequences of vascular calcification. Front Endocrinol (Lausanne) 2012;3:95.
15. Johnson RC, Leopold JA, Loscalzo J. Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 2006;99: 1044-59.
16. Demer LL, Tintut Y. Vascular calcification: pathobiology of a multifaceted disease. Circulation 2008;117:2938-48.
17. Iribarren C, Sidney S, Sternfeld B, Browner WS. Calcification of the aortic arch: risk factors and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA 2000;283:2810-5.
18. Walsh CR, Cupples LA, Levy D, Kiel DP, Hannan M, Wilson PW, O'Donnell CJ. Abdominal aortic calcific deposits are associated with increased risk for congestive heart failure: the Framingham Heart Study. Am Heart J 2002;144:733-9.
19. van der Meer IM, Bots ML, Hofman A, del Sol AI, van der Kuip DA, Witteman JC. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 2004;109:1089-94.
20. Wilson PW, Kauppila LI, O'Donnell CJ, Kiel DP, Hannan M, Polak JM, Cupples LA. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 2001;103:1529-34.
21. Greenland P, Smith SC, Jr., Grundy SM. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation 2001;104: 1863-7.
22. Shanahan CM. Vascular calcification-a matter of damage limitation? Nephrol Dial Transplant 2006;21:1166-9.
23. Burgess NA, Reynolds TM, Williams N, Pathy A, Smith S. Evaluation of four animal models of intrarenal calcium deposition and assessment of the influence of dietary supplementation with essential fatty acids on calcification. Urol Res 1995;23:239-42.
24. Abedin M, Lim J, Tang TB, Park D, Demer LL, Tintut Y. N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways. Circ Res 2006;98:727-9.
25. Heine-Bröring RC, Brouwer IA, Proenca RV, van Rooij FJ, Hofman A, Oudkerk M, Witteman JC, Geleijnse JM. Intake of fish and marine n-3 fatty acids in relation to coronary calcification: the Rotterdam Study. Am J Clin Nutr 2010;91:1317-23.
26. He K, Liu K, Daviglus ML, Mayer-Davis E, Jenny NS, Jiang R, Ouyang P, Steffen LM, Siscovick D, Wu C, et al. Intakes of long-chain n-3 polyunsaturated fatty acids and fish in relation to measurements of subclinical atherosclerosis. Am J Clin Nutr 2008;88:1111-8.
27. Giles GG, English DR. The Melbourne Collaborative Cohort Study. IARC Sci Publ 2002;156:69-70.
28. Ireland P, Jolley D, Giles G, O'Dea K, Powles J, Rutishauser I,Wahlqvist ML, Williams J. Development of the Melbourne FFQ: a food frequency questionnaire for use in an Australian prospective study involving an ethnically diverse cohort. Asia Pac J Clin Nutr 1994;3:19-31.
29. RMIT Lipid Research Group. Food acid compositional database. Brisbane (Australia): Xyris software; 2001.
30. Lester IH. Nutrient data table for use in Australia. NUTTAB 95. Canberra (Australia): AGPS; 1995.
31. National Heart Foundation and Australian Institute of Health. Risk Factor Prevalence Study No. 3 1989. Canberra (Australia): National Heart Foundation and Australian Institute of Health; 1990.
32. Australian Bureau of Statistics. Index of relative socio-economic advantage and disadvantage. ABS Catalogue no. 2033055001. Canberra (Australia): Australian Bureau of Statistics; 1996.
33. Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997;132:245-50.
34. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65:1220S-8S; discussion 9S-31S.
35. Sekikawa A, Miura K, Lee S, Fujiyoshi A, Edmundowicz D, Kadowaki T, Evans RW, Kadowaki S, Sutton-Tyrrell K, Okamura T, et al. Long chain n-3 polyunsaturated fatty acids and incidence rate of coronary artery calcification in Japanese men in Japan and white men in the USA: population based prospective cohort study. Heart 2014;100:569-73.
36. Matsuzaki M, Yokoyama M, Saito Y, Origasa H, Ishikawa Y, Oikawa S, Sasaki J, Hishida H, Itakura H, Kita T, et al. Incremental effects of eicosapentaenoic acid on cardiovascular events in statin-treated patients with coronary artery disease. Circ J 2009;73:1283-90.
37. Wen YT, Dai JH, Gao Q. Effects of omega-3 fatty acid on major cardiovascular events and mortality in patients with coronary heart disease: a meta-analysis of randomized controlled trials. Nutrition, metabolism, and cardiovascular diseases. Nutr Metab Cardiovasc Dis 2014;24:470-5.
38. McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med 2014;126:54-64.
39. Luo C, Zhang Y, Ding Y, Shan Z, Chen S, Yu M, Hu FB, Liu L. Nut consumption and risk of type 2 diabetes, cardiovascular disease, and allcause mortality: a systematic review and meta-analysis. Am J Clin Nutr 2014;100:256-69.
40. Afshin A, Micha R, Khatibzadeh S, Mozaffarian D. Consumption of nuts and legumes and risk of incident ischemic heart disease, stroke, and diabetes: a systematic review and meta-analysis. Am J Clin Nutr 2014;100:278-88.
41. Howe P, Meyer B, Record S, Baghurst K. Dietary intake of long-chain omega-3 polyunsaturated fatty acids: contribution of meat sources. Nutrition 2006;22:47-53.
42. Mozaffarian D, Micha R, Wallace S. Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLoS Med 2010;7:e1000252.
43. Amiano P, Machon M, Dorronsoro M, Chirlaque MD, Barricarte A, Sanchez MJ, Navarro C, Huerta JM, Molina-Montes E, Sanchez-Cantalejo E, et al. Intake of total omega-3 fatty acids, eicosapentaenoic acid and docosahexaenoic acid and risk of coronary heart disease in the Spanish EPIC Cohort Study. Nutr Metab Cardiovasc Dis 2014;24:321-7.
44. Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, Kokubo Y, Tsugane S. Intake of fish and n-3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation 2006;113:195-202.
45. Ascherio A, Rimm EB, Stampfer MJ, Giovannucci EL, Willett WC. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med 1995;332:977-82.
46. Hu FB, Bronner L, Willett WC, Stampfer MJ, Rexrode KM, Albert CM, Hunter D, Manson JE. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA 2002;287: 1815-21.
47. Burdge GC, Wootton SA. Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women. Br J Nutr 2002;88:411-20.
48. Burdge GC, Jones AE, Wootton SA. Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men. Br J Nutr 2002;88:355-63.
49. Hodge AM, Simpson JA, Gibson RA, Sinclair AJ, Makrides M, O'Dea K, English DR, Giles GG. Plasma phospholipid fatty acid composition as a biomarker of habitual dietary fat intake in an ethnically diverse cohort. Nutr Metab Cardiovasc Dis 2007;17:415-26.